CYP19A1 Expression Is Controlled by mRNA Stability of the Upstream Transcription Factor AP-2γin Placental JEG3 Cells

Research output: Contribution to journalArticlepeer-review

Abstract

CYP19A1 encodes aromatase, which converts testosterone to estrogen, and is induced during placental maturation. To elucidate the molecular mechanism underlying this function, histone methylation was analyzed using the placental cytotrophoblast cell line, JEG3. Treatment of JEG3 cells with 3-deazaneplanocin A, an inhibitor of several methyltransferases, resulted in increased CYP19A1 expression, accompanied by removal of the repressive mark H3K27me3 from the CYP19A1 promoter. However, this increase was not observed in cells treated with GSK126, another specific inhibitor for H3K27me3 methylation. Expression of TFAP2C, which encodes AP-2γ, a transcription factor that regulates CYP19A1, was also elevated on 3-deazaneplanocin A treatment. Interestingly, TFAP2C messenger RNA (mRNA) was readily degraded in JEG3 cells but protected from degradation in the presence of 3-deazaneplanocin A. TFAP2C mRNA contained N6-methyladenosines, which were reduced on drug treatment. These observations indicate that the TFAP2C mRNA undergoes adenosine methylation and rapid degradation, whereas 3-deazaneplanocin A suppresses methylation, resulting in an increase in AP-2γlevels. We conclude that the increase in AP-2γexpression via stabilization of the TFAP2C mRNA is likely to underlie the increased CYP19A1 expression.

Original languageEnglish
Article numberbqae055
JournalEndocrinology
Volume165
Issue number6
DOIs
Publication statusPublished - 01-06-2024

All Science Journal Classification (ASJC) codes

  • Endocrinology

Fingerprint

Dive into the research topics of 'CYP19A1 Expression Is Controlled by mRNA Stability of the Upstream Transcription Factor AP-2γin Placental JEG3 Cells'. Together they form a unique fingerprint.

Cite this